Natura audit, risk and finance committee backs 2Q26 financial statements for board approval

• Natura’s audit, risk management, and finance committee met July 31, 2026 to review the company’s Q2 2026 interim financial statements.
• The committee backed the individual and consolidated quarterly information for the three months ended June 30, 2026, with no reservations.
• It also endorsed the accompanying notes and the draft external auditors’ report.
• The committee will recommend that the board approve the Q2 2026 quarterly information.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Natura Cosmeticos SA published the original content used to generate this news brief on August 10, 2026, and is solely responsible for the information contained therein.